Published in C R Acad Sci Hebd Seances Acad Sci D on January 16, 1978
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
Vasoactive intestinal polypeptide: specific binding to rat brain membranes. Proc Natl Acad Sci U S A (1979) 0.97
Separation of antibody-bound and unbound peptide hormones labelled with iodine-131 by talcum powder and precipitated silica. Nature (1966) 3.17
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Acute hepatitis C infection in HIV positive men who have sex with men in Paris, France, 2001-2004. Euro Surveill (2005) 2.20
Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects. J Urol (2001) 2.15
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (2000) 2.14
Genotyping of Helicobacter pylori isolates by sequencing of PCR products and comparison with the RAPD technique. Res Microbiol (1996) 2.11
Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity (1998) 1.96
A 2-year study of Helicobacter pylori in children. J Clin Microbiol (1994) 1.80
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia (1980) 1.74
Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71
O-acetylated peptidoglycan: its occurrence, pathobiological significance, and biosynthesis. Can J Microbiol (1992) 1.65
Quality of referral letters. Lancet (2002) 1.58
The role of cisapride in the treatment of pediatric gastroesophageal reflux. The European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (1999) 1.56
Small-bowel bacterial overgrowth in children with chronic diarrhea, abdominal pain, or both. J Pediatr (1996) 1.52
Allergy to extensively hydrolyzed cow milk proteins in infants: identification and treatment with an amino acid-based formula. J Pediatr (1997) 1.50
Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation. Sleep Med (2006) 1.44
Duodenogastric reflux in children: measurement of phospholipids and trypsin in gastric content. J Pediatr Gastroenterol Nutr (1990) 1.44
The atopy patch tests for detection of cow's milk allergy with digestive symptoms. J Pediatr (2003) 1.42
[Feeding of infants based on age. Practice guidelines]. Arch Pediatr (2003) 1.40
Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J Bone Joint Surg Br (2007) 1.38
Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin. J Cell Physiol (1985) 1.30
Current concepts and issues in the management of regurgitation of infants: a reappraisal. Management guidelines from a working party. Acta Paediatr (1996) 1.27
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest (2001) 1.27
Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology (1994) 1.27
Diabetogenic effect of streptozotocin in the rat during the perinatal period. Diabetes (1974) 1.27
2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? J Med Genet (2008) 1.25
High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J Clin Microbiol (2001) 1.25
Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci U S A (1994) 1.24
Vasoactive intestinal peptide: a potent stimulator of adenosine 3':5'-cyclic monophosphate accumulation in gut carcinoma cell lines in culture. Proc Natl Acad Sci U S A (1978) 1.21
Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet (1999) 1.20
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial. J Pediatr (2001) 1.16
Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem (1988) 1.16
Catalysis and specificity in enzymatic glycoside hydrolysis: a 2,5B conformation for the glycosyl-enzyme intermediate revealed by the structure of the Bacillus agaradhaerens family 11 xylanase. Chem Biol (1999) 1.15
Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol (1999) 1.15
Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG (2010) 1.14
A heterotrimeric Gi3-protein controls autophagic sequestration in the human colon cancer cell line HT-29. J Biol Chem (1995) 1.14
Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1. Cell Death Differ (1999) 1.13
[Absence of effect of cisapride on heart rate]. Presse Med (1991) 1.13
Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon. Biochem Biophys Res Commun (1998) 1.13
A novel polymorphic genetic locus in members of the Mycobacterium tuberculosis complex. Microbiology (1999) 1.13
Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2. Br J Cancer (2001) 1.12
[The effects of perfusion and amino acid ingestion in glucagonenemia]. Journ Annu Diabetol Hotel Dieu (1967) 1.11
Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat. FEBS Lett (1980) 1.11
Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice. Int J Cancer (1999) 1.10
Metastatic cutaneous Crohn's disease in a child. J Pediatr Gastroenterol Nutr (1998) 1.08
Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors. Am J Physiol (1992) 1.07
Rotavirus induces alpha-interferon release in children with gastroenteritis. J Pediatr Gastroenterol Nutr (1993) 1.07
Oral food challenge in children: an expert review. Eur Ann Allergy Clin Immunol (2009) 1.06
The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. J Hypertens (1996) 1.05
New alpha-L-arabinofuranosidase produced by Streptomyces lividans: cloning and DNA sequence of the abfB gene and characterization of the enzyme. Biochem J (1997) 1.03
Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology (1974) 1.03
Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane. Biochemistry (1996) 1.02
High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed (2004) 1.02
Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy (2006) 1.02
Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy (2009) 1.01
Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci (2003) 1.01
Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children. Antimicrob Agents Chemother (1998) 1.01
Demonstration of specific receptors for EGF--urogastrone in isolated rat intestinal epithelial cells. FEBS Lett (1980) 1.01
Chicken insulin: radioimmunological characterization and enhanced activity in rat fat cells and liver plasma membranes. Endocrinology (1974) 1.01
Eosinophilic gastrointestinal diseases (EGIDs). J Pediatr Gastroenterol Nutr (2008) 1.00
Interaction of vasoactive intestinal peptide (VIP) with a mouse adrenal cell line (Y-1): specific binding and biological effects. Biochem Biophys Res Commun (1979) 1.00
Modifications of intestinal permeability during food provocation procedures in pediatric irritable bowel syndrome. J Pediatr Gastroenterol Nutr (1990) 1.00
Substrate specificity in glycoside hydrolase family 10. Structural and kinetic analysis of the Streptomyces lividans xylanase 10A. J Biol Chem (2000) 1.00
High plasma nonesterified fatty acids are predictive of cancer mortality but not of coronary heart disease mortality: results from the Paris Prospective Study. Am J Epidemiol (2001) 0.99
Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine. Eur J Clin Invest (1980) 0.99
Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization. Ann Thorac Surg (1998) 0.99
Galanin receptor in the rat pancreatic beta cell line Rin m 5F. Molecular characterization by chemical cross-linking. J Biol Chem (1989) 0.99
Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors. Endocrinology (1989) 0.98
Immunoblotting and serology for diagnosis of Helicobacter pylori infection in children. Pediatr Infect Dis J (2000) 0.98
Expression of glucagon-like peptide 1 receptor in a murine C cell line: regulation of calcitonin gene by glucagon-like peptide 1. FEBS Lett (1996) 0.98
Evidence for the presence of insulin binding sites in isolated rat intestinal epithelial cells. Diabetologia (1980) 0.97
Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis. Pediatr Allergy Immunol (2001) 0.97
Chromosome 22q13.3 deletion syndrome with a de novo interstitial 22q13.3 cryptic deletion disrupting SHANK3. Eur J Med Genet (2009) 0.97
Expression of functional HIV-1 integrase in the yeast Saccharomyces cerevisiae leads to the emergence of a lethal phenotype: potential use for inhibitor screening. Curr Genet (1996) 0.97
Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun (1994) 0.96
Sensitisation to peanut and vitamin D oily preparations. Lancet (1993) 0.96
The Streptomyces lividans family 12 endoglucanase: construction of the catalytic cre, expression, and X-ray structure at 1.75 A resolution. Biochemistry (1997) 0.96
Clarithromycin resistance and eradication of Helicobacter pylori in children. Antimicrob Agents Chemother (2001) 0.96
Glucagon antibodies. Lancet (1965) 0.95
The crystal structure of a 2-fluorocellotriosyl complex of the Streptomyces lividans endoglucanase CelB2 at 1.2 A resolution. Biochemistry (1999) 0.95
Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP. Biochem Biophys Res Commun (1995) 0.95
Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia (1979) 0.95
Identification and molecular characterization of galanin receptor sites in rat brain. Biochem Biophys Res Commun (1987) 0.95
Cholera-induced mucin secretion from rat intestine: lack of effect of cAMP, cycloheximide, VIP, and colchicine. Am J Physiol (1984) 0.94
Interaction of peptide YY with rat intestinal epithelial plasma membranes: binding of the radioiodinated peptide. Endocrinology (1986) 0.93